NABULSI AZMI (Chief Operating Officer) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2025ACC: 0000950170-25-031034
Officer· Chief Operating Officer
Since Oct 2019
+134.20K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
134.20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+79.20K
Price / share
—
Trade value
—
% of position
33.9%
2/27/2025
233.39K→312.59K
Total
Net shares
+79.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2025 | A · Award | +79.20K | — | — | 33.9% | 233.39K | 312.59K |
| Total | +79.20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
55K shares
Shares
+55K
Strike price
5.76
Held after
55K
Exercisable
—
2/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock55K shares | 2/27/2025 | A · Award | +55K | 5.76 | — | 55K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.58K
Common Stock
IndirectShares owned785.70K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.58K | Indirect |
| Common Stock | 785.70K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported